Recall Enforment Report D-0178-2021

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Ascend Laboratories LLC, originally initiated on 12-17-2020 for the product Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 100 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88 The product was recalled due to failed impurity/degradation specifications. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0178-202112-17-202001-06-2021Class II29,317 bottlesAscend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 100 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88Failed Impurity/Degradation SpecificationsTerminated
D-0179-202112-17-202001-06-2021Class II9,524 bottlesAscend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68Failed Impurity/Degradation SpecificationsTerminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
67877-544Cephalexin CephalexinFor SuspensionOralAscend Laboratories, LlcHuman Prescription Drug
67877-545Cephalexin CephalexinFor SuspensionOralAscend Laboratories, LlcHuman Prescription Drug